Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study JOURNAL OF NEUROSURGERY Steinberg, G. K., Kondziolka, D., Wechsler, L. R., Lunsford, L., Kim, A. S., Johnson, J. N., Bates, D., Poggio, G., Case, C., McGrogan, M., Yankee, E. W., Schwartz, N. E. 2019; 131 (5): 1462–72

View details for DOI 10.3171/2018.5.JNS173147

View details for Web of Science ID 000493973300015